292 related articles for article (PubMed ID: 33177824)
1. Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of
Rebouças-Silva J; Tadini MC; Devequi-Nunes D; Mansur AL; S Silveira-Mattos P; I de Oliveira C; R Formiga F; Berretta AA; Marquele-Oliveira F; Borges VM
Int J Nanomedicine; 2020; 15():8659-8672. PubMed ID: 33177824
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models.
Riaz A; Hendricks S; Elbrink K; Guy C; Maes L; Ahmed N; Kiekens F; Khan GM
AAPS PharmSciTech; 2020 Jul; 21(5):185. PubMed ID: 32632542
[TBL] [Abstract][Full Text] [Related]
3. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
4. Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles.
Sousa-Batista AJ; Pacienza-Lima W; Ré MI; Rossi-Bergmann B
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():148-155. PubMed ID: 31331828
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
Kar N; Chakraborty S; De AK; Ghosh S; Bera T
Eur J Pharm Sci; 2017 Jun; 104():196-211. PubMed ID: 28400285
[TBL] [Abstract][Full Text] [Related]
6. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
7. Method validation and nanoparticle characterization assays for an innovative amphothericin B formulation to reach increased stability and safety in infectious diseases.
Tadini MC; de Freitas Pinheiro AM; Carrão DB; Aguillera Forte ALS; Nikolaou S; de Oliveira ARM; Berretta AA; Marquele-Oliveira F
J Pharm Biomed Anal; 2017 Oct; 145():576-585. PubMed ID: 28777969
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
Solomon M; Pavlotzky F; Barzilai A; Schwartz E
J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Santos DM; Petersen AL; Celes FS; Borges VM; Veras PS; de Oliveira CI
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3275. PubMed ID: 25340794
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
[TBL] [Abstract][Full Text] [Related]
11. Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment.
Galvão JG; Santos RL; Silva ARST; Santos JS; Costa AMB; Chandasana H; Andrade-Neto VV; Torres-Santos EC; Lira AAM; Dolabella S; Scher R; Kima PE; Derendorf H; Nunes RS
Eur J Pharm Sci; 2020 Jul; 150():105335. PubMed ID: 32272211
[TBL] [Abstract][Full Text] [Related]
12. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
13. Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis.
Riezk A; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
Molecules; 2020 Sep; 25(17):. PubMed ID: 32887341
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
Nimtrakul P; Tiyaboonchai W; Lamlertthon S
Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
[TBL] [Abstract][Full Text] [Related]
15. Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro.
Perez AP; Altube MJ; Schilrreff P; Apezteguia G; Celes FS; Zacchino S; de Oliveira CI; Romero EL; Morilla MJ
Colloids Surf B Biointerfaces; 2016 Mar; 139():190-8. PubMed ID: 26709977
[TBL] [Abstract][Full Text] [Related]
16. Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice.
de Carvalho RF; Ribeiro IF; Miranda-Vilela AL; de Souza Filho J; Martins OP; Cintra e Silva Dde O; Tedesco AC; Lacava ZG; Báo SN; Sampaio RN
Exp Parasitol; 2013 Oct; 135(2):217-22. PubMed ID: 23891944
[TBL] [Abstract][Full Text] [Related]
17. The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis.
Gürbüz Çolak N; Çetin Uyanikgil EÖ; Özbel Y; Töz S
Acta Parasitol; 2022 Sep; 67(3):1354-1363. PubMed ID: 35857275
[TBL] [Abstract][Full Text] [Related]
18. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations.
Jansook P; Pichayakorn W; Ritthidej GC
Drug Dev Ind Pharm; 2018 Oct; 44(10):1693-1700. PubMed ID: 29936874
[TBL] [Abstract][Full Text] [Related]
19. Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.
Franco-Muñoz C; Manjarrés-Estremor M; Ovalle-Bracho C
PLoS One; 2018; 13(4):e0196247. PubMed ID: 29698432
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
